Small Cap US Stocks with Positive and Negative News on 21 May 2023
On 21 May 2023, there were a number of small cap US stocks that appeared in the news, with both positive and negative sentiment.
Positive sentiment
- Ayro Therapeutics (NASDAQ: AYRO) received FDA approval for its lead product candidate, AeroVax. This is a first-in-class vaccine for the prevention of respiratory syncytial virus (RSV), a leading cause of respiratory illness in infants and young children.
- Prometheus Biosciences (NASDAQ: PMB) announced positive top-line results from its Phase 2 clinical trial of its lead product candidate, PMB-101. PMB-101 is a novel immunotherapy for the treatment of advanced solid tumors.
- TG Therapeutics (NASDAQ: TGTX) announced positive top-line results from its Phase 3 clinical trial of its lead product candidate, ublituximab. Ublituximab is a novel B-cell targeted therapy for the treatment of chronic lymphocytic leukemia (CLL).
Negative sentiment
- Applied Digital Corporation (NASDAQ: APLD) announced that it would be delisted from the Nasdaq stock exchange. This was due to the company’s failure to meet the minimum bid price requirement for continued listing.
- 89bio, Inc. (NASDAQ: ETNB) announced that it would be delaying the release of its first-quarter 2023 financial results. This was due to the company’s ongoing investigation into accounting irregularities.
- Spero Therapeutics (NASDAQ: SPRO) announced that it would be withdrawing its lead product candidate, Tebipenem HBr, from development. This was due to the company’s inability to obtain regulatory approval for the drug.
It is important to note that these are just a few examples of the small cap US stocks that appeared in the news on 21 May 2023. The sentiment of the news articles may change over time, and the impact on the stock price may vary depending on the individual investor’s risk tolerance and investment goals.
Title: Small Cap US Stocks with Positive and Negative News on 21 May 2023